WHO ICTRP trial
Effect, Safety and Pharmacokinetics Study of PRO051 to Treat DMD
NL-OMON21367 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON21367 |
|---|---|
| Public title | Effect, Safety and Pharmacokinetics Study of PRO051 to Treat DMD |
| Scientific title | A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess the Effect, Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Doses of PRO051 in Patients With Duchenne Muscular Dystrophy |
| Primary sponsor | Prosensa |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | Duchenne Muscular Dystrophy |
| Interventions | Subcutaneous injection of PRO051, once a week, for 5 weeks, different dose per group, 4 groups |
| Registration date | Mar 7, 2008 |
| Target size | 18 |
| Secondary IDs | NL1196;NTR1241;EC Leuven : OG032;ISRCTN wordt niet meer aangevraagd |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: